IBC0966
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IBC0966, covering 2023-03-10 to 2023-03-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors [Phase 1, Phase 2]